QNRX 424B3: Secondary offering
Quoin Pharmaceuticals Ltd.
Filed with the SEC on · accession 0001104659-26-111012
QNRX filed a 424B3 (prospectus (offering)) with the SEC on Sep 25, 2026. Quoin Pharmaceuticals Ltd. filed a prospectus for the resale of up to 9,371,895 ADSs by selling shareholders, representing 328,016,325 ordinary shares. The stock moved +0.8% by the first close after the filing.
Summary of the filing
Quoin Pharmaceuticals Ltd. filed a prospectus for the resale of up to 9,371,895 ADSs by selling shareholders, representing 328,016,325 ordinary shares. The company will not receive proceeds from the resale but could receive up to $19.1 million if all ordinary warrants are exercised for cash.
Key details
How QNRX stock reacted
Close before
$6.38
Sep 24, 2026
First close after
+0.78%
$6.43
5 trading days
-26.02%
$4.72
Since filing
-40.44%
$3.80
✦ Ask GOAX AI about this filing — what it means for QNRX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for QNRX?
Click hereFrequently asked questions
What did QNRX file with the SEC on Sep 25, 2026?
QNRX filed a 424B3 (Secondary offering). Quoin Pharmaceuticals Ltd. filed a prospectus for the resale of up to 9,371,895 ADSs by selling shareholders, representing 328,016,325 ordinary shares. The company will not receive proceeds from the resale but could receive up to $19.1 million if all ordinary warrants are exercised for cash.
What does a secondary offering mean for QNRX stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B3?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did QNRX stock react to this filing?
QNRX closed at $6.38 before the filing and $6.43 on Sep 25, 2026 (+0.78%). Five trading days later: $4.72 (-26.02%).
Other QNRX SEC filings
- 10-Q · SEC filingNov 5, 2026
- EFFECT · Shelf registrationNov 4, 2026
- 8-K · SEC filingNov 4, 2026
- 424B5 · Shelf registrationNov 4, 2026
- 424B5 · Shelf registrationNov 4, 2026
- S-3 · Shelf registrationOct 28, 2026
- 8-K · SEC filingOct 20, 2026
- 8-K · SEC filingOct 14, 2026
- DEF 14A · SEC filingOct 2, 2026
- EFFECT · SEC filingSep 25, 2026
Get alerts when QNRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days